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Abstract 
Background: Parallel up-regulation of several T-cell effector functions 
(‘polyfunctionality’) is believed to be critical for the protection against viruses but thought 
to decrease in large T-cell expansions, in particular at older ages. The factors 
determining T-cell polyfunctionality are incompletely understood. Here we revisit the 
question of CMV-specific T-cell polyfunctionality, including a wide range of T-cell target 
proteins, response sizes, and participant ages. Methods: Polychromatic flow-cytometry 
was used to analyze the functional diversity (CD107, CD154, IL-2, TNF, IFN-) of CD4 
and CD8 T-cell responses to 19 CMV proteins in a large group of young and older UK 
participants. A group of oldest old people (>85years) was included to explore these 
parameters in exceptional ‘survivors’. Polyfunctionality was assessed for each protein-
specific response subset by subset and in aggregate across all proteins using the novel 
polyfunctionality index (PI).  
Results: Polyfunctionality was not reduced in healthy older compared to young people. 
However, it was significantly related to target protein specificity. For each protein it 
increased with response size. In the oldest old overall T-cell polyfunctionality was 
significantly lower. 
Discussion: Our results give a new perspective on T-cell polyfunctionality and raise the 
question if maintaining polyfunctionality of CMV-specific T-cells at older ages is 
necessarily benefi ial. (abstract word count: 200 words) 
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Introduction 
The numbers of fresh, naïve cells leaving the thymus declines early in life. However, T-
cell numbers are maintained at a constant level in adults [1] because memory T-cells 
proliferate to compensate for this shortfall. Cytomegalovirus (CMV) appears to be a 
uniquely effective driver of this compensatory proliferation, sometimes producing very 
large T-cell expansions [2, 3]. It is unclear how these changes affect the functional 
diversity (‘polyfunctionality’) of T-cells. Polyfunctionality is an important T-cell quality, 
which has been linked to protection in certain vaccine models [4-7]. Several studies 
have explored T-cell polyfunctionality at older ages but it is not known whether this 
varies with respect to CMV protein target and/or response size. Previous work on CMV-
related T-cell polyfunctionality has focused on just one or two frequently recognized,  
‘dominant’ CMV proteins [8, 9] but it is unlikely that the polyfunctionality of one or two 
dominant responses sufficiently captures the overall polyfunctionality of the T-cell 
response to this pathogen (including dominant and subdominant responses) [10]. We 
therefore decided to revisit this interesting question taking into account a wider, more 
representative range of CMV target proteins than previously studied. By analyzing 5 
functional read-outs for CD4 and CD8 T-cell responses to the 19 most representative 
CMV target proteins [11] in young and older people, we explored whether 
polyfunctionality is fully preserved in older people and how this is  linked to target 
protein specificity and response size.  
 at Sussex Language Institute on A
ugust 12, 2016
http://jid.oxfordjournals.org/
D
ow
nloaded from
 
Ac
ce
pte
d M
an
us
cri
pt
5 
 
Methods 
Ethics statement 
This study was approved by the UK National Research Ethics Service (NRES) 
(09/H1102/84). Written informed consent was obtained from all participants. The study 
was conducted in agreement with the Declaration of Helsinki. 
 
Blood donors 
As part of a larger study, CMV-specific T-cell responsiveness was examined in CMV-
infected (IgG-seropositive, ‘CMV+’) ‘young’ (19-35 years old) and  ‘older’ (60-85 years 
old) individuals in East Sussex, UK. Healthy young volunteers included university 
students/staff; healthy older volunteers were recruited through general practitioners 
affiliated to the UK National Institute of Health Research (NIHR) Primary Care Research 
Network. Exclusion criteria were; known immunodeficiency (including HIV-infection), 
organ transplantation, use of immunosuppressive or immunomodulating drugs within 
the last year (excluding acetylsalicylic acid ≤ 100mg/day), current neoplastic disease or 
treatment for cancer within the previous 5 years, insulin dependent diabetes, moderate 
or advanced renal failure, liver disease, endocrine disorders (except corrected thyroid 
dysfunction), autoimmune disease, dementia/mental incapacity, alcohol/other drug 
abuse, acute infection or illness in the last 4 weeks, and raised body temperature 
(>37.5° C).  
An additional 22 CMV+ individuals with previously known T-cell responsiveness to CMV 
were recruited in Parma/Italy as a comparison group of particularly advanced age (85 – 
102 years) (referred to as ‘oldest old’). Inclusion criteria for Italian volunteers were; 
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minimum age 85 years, known CMV responsiveness; exclusion criteria were; evidence 
of endocrine (except thyroid dysfunction), autoimmune and neoplastic diseases, acute 
infections or illness in the last 2 months, renal or liver failure, and use of immune-
modulatory medications (including steroids, non-steroidal anti-inflammatory agents, 
acetylsalicylic acid >100mg/day, or immunosuppressive drugs). Individuals with 
cerebrovascular and/or cardiovascular disease were accepted, as the goal was to 
include individuals representative of such an advanced age cohort. Demographics are 
shown in Table 1. 
 
CMV status 
CMV Serology (Architect CMV IgG, Abbot, Maidenhead, UK) was performed in the 
Brighton and Sussex University Hospital Trust (BSUHT) virology laboratory.  
 
Peripheral blood mononuclear cell (PBMC) Isolation and activation 
PBMC were isolated from fresh, sodium heparin-anticoagulated venous blood by 
density gradient centrifugation (Ficoll-Hypaque, PLUS Healthcare, Buckinghamshire, 
UK) [12]. PBMC were resuspended at 5 x 106 cells/mL in complete RPMI (Fisher 
Scientific, Loughborough, UK) containing 10% fetal calf serum (Fisher). Twenty-five μg 
per peptide of CMV peptide-pools (“PepMix”, JPT Peptide Technologies, Berlin, 
Germany) was dissolved in 100 μL of dimethyl-sulfoxide (Sigma-Aldrich, Gillingham, 
UK). 2 μL of peptide solution, 1.5 μL of anti CD107a (BD) and 0.5 μL of Monensin (BD) 
were added to 56 μL of complete media and placed in 4.5 mL polystyrene tubes (BD). 
Then 200 μL of PBMC suspension was added and tubes were incubated at 37°C in a 
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standard incubator in a humidified 5% CO2 atmosphere. Brefeldin A (5 μg/ml; Sigma) 
was added after 2 hours and samples were incubated for additional 14 hours. Final 
concentrations of peptide were 1 μg/mL per peptide for each pool. Staphylococcus 
enteroxin B (SEB) (Sigma) was dissolved in DMSO and used at 1 μg/ml (final 
concentration) as positive stimulation control; peptide solvent (DMSO) alone served as 
a negative control. At the end of the incubation time 100 μl of a 20 mM EDTA buffer was 
added to each tube and incubation continued for 10 min at 37oC. EDTA buffer was 
freshly prepared by adding Na-EDTA (Sigma) to ‘wash buffer’ consisting of PBS 
supplemented with 0.5% bovine serum albumin and 0.1% sodium azide (Sigma). Tubes 
were vortexed and then incubated for a further 10 min at 37°C. After spinning at 400g 
for 8 min at 4°C, pellets were washed once more with wash buffer (same centrifuge 
settings) and then resuspended for staining. 
 
CMV Peptide Pools  
Peptides (15 amino acids length, 11 overlaps between adjacent peptides) covering the 
amino acid sequences for CMV proteins UL28, UL32, UL36, UL48, UL55, UL82, UL83, 
UL86, UL94, UL99, UL103, UL122, UL123, UL151, UL153, US3, US24, US29, US32 
were prepared by solid-phase synthesis [11, 13]. All peptides were quality controlled by 
mass spectroscopy and HPLC. Peptide purity was > 80%. One single pool was 
generated for each protein, except for the largest protein, UL48, for which two pools 
were generated (‘Pepmix’, JPT Peptide Technologies, Berlin, Germany). Freeze-dried 
pools were stored at -80°C. The 19 original CMV peptide pools were arranged in 16 
stimulation pools, of which 12 pools contained just one protein (expected to elicit 
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frequent responses) and 4 pools contained 2 proteins each (expected to elicit less 
frequent responses) (Table 2).  
 
 
Antibodies 
We used the following fluorescence-conjugated monoclonal antibodies and staining 
reagents: anti-CD3-v500, anti-CD8-Allophyocyanine(APC)-H7, anti-CD27-
Phycoerythrine(PE) , IL-2-Fluoresceine-iso-thio-cyanate(FITC) , TNF-α- Alexa 700 , 
CD107a-APC (all BD Biosciences, Oxford, UK), anti-CD4-Peridinin chlorophyll 
(PerCP), anti-IFN- PE-Cy7 (Cyanine 7), anti-CD154 Pacific-Blue (BioLegend, 
Cambridge, UK), anti-CD45RA-ECD (Beckman Coulter, UK), Yellow live-dead stain 
(Invitrogen, Paisley, UK).  
 
Intracellular Cytokine Staining 
Staining antibodies were added and tubes incubated for 30 minutes at 4°C. After a 
further wash, red blood cells were lysed with FACS Lysing solution (BD) and then 
permeabilized with BD Permeabilizing solution 2 (BD) according to the manufacturer's 
instructions. Cells were then stained intracellularly following the same steps as used for 
surface staining. Following a final wash, pellets were resuspended and fixed in PBS 
containing 0.5% paraformaldehyde (Sigma) prior to acquisition on an LSRII flow 
cytometer using FACSdiva 6.1 software (BD). 
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Data analysis and Gating strategy 
After stimulation activated cells were enumerated by flow-cytometry using five 
simultaneous T-cell activation read-outs, CD107, CD154, IL-2, TNF, IFN-. Data 
analysis was performed with FlowJo-v9.x software (TreeStar Inc., Ashland, USA). 
Details of the gating strategy are available on-line  (Supplementary Fig. S1). Individual 
gates were set on activation marker-positive CD4 and CD8 T-cells. These were 
combined using the Boolean gate function in FlowJo generating 32 subsets (31 
functional subsets, 1 without any of the tested functions). Net subset frequencies were 
determined by background subtraction (subset by subset). Responses were considered 
negative if they were not identifiable by at least one activation marker and a visible cell 
cluster exceeding 1/10,000 CD4 or CD8 T-cells (0.01%).  
 
Polyfunctionality 
SPICE software was used to visualize and analyze non-overlapping functional subsets 
[14]. The polyfunctionality index (PI) algorithm was obtained from ‘FunkyCells ToolBox’ 
version 0.1.0 beta (www.FunkyCells.com) [15]. To calculate the PI, each subset defined 
by a given number of displayed functions has a weight assigned which is then multiplied 
with the subset frequency. The PI is the sum of these products (PI = 








n
i
q
i
n
i
F
0
where 
Fi is the frequency of cells performing i simultaneous functions, q is the polyfunctionality 
parameter determining the weight of the subsets, n is the number of possible functions). 
The polyfunctionality parameter q was set to 1 as previously described [15]. Samples 
containing less than 0.1% activated events were not included in correlations of PI and 
other parameters. 
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Statistical analysis 
SPSS v22 software (IBM, London, UK) was used for statistical analysis. Non-parametric 
tests (Mann-Whitney) were used to compare groups unless normality of data distribution 
was assumed (Q/Q plots, and the Kolmogorov-Smirnov test). Differences between more 
than two groups (independent samples) were tested with the Kruskal-Wallis test. 
Differences with respect to several parameters (related samples) were tested with 
Friedman’s ANOVA. Where appropriate T-cell frequencies were log-transformed  to 
normalize distribution or improve visual presentation. P-values <0.05 were considered 
significant for single endpoints. Where there were multiple end-points Bonferroni 
correction was applied to adjust the significance level from p≤0.05 to p≤0.05/n, where n 
is the number of endpoints.  
 
Results 
The functional T-cell subset distribution is very similar in young and older UK 
participants 
CMV-specific CD4 and CD8 T-cells were analyzed in a healthy UK cohort (two age 
groups) and a cohort of oldest old Italians.  The main interest in the latter was to 
contrast findings in the older group (within the normal life expectancy) against 
exceptional survivors. They were not considered examples of ‘normal’ ageing.  
After stimulating PBMC with 19 representative CMV target proteins the five 
simultaneously measured T-cell activation read-outs (CD107, CD154, IL-2, TNF, IFN-) 
gave rise to n=32 functional (Boolean) subsets when positive/negative populations were 
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gated for each marker (n=25), however, the subset negative for all markers was 
discounted from the analysis leaving 31; these were visualized using SPICE software 
[14]. However, none of the functional CD4 or CD8 T-cell subsets was significantly 
different between the young and the older UK participants when analyzing UL83-
specific responses (Supplementary Fig. S2); this was also true for UL55-specific CD4 
and UL123-specific CD8 T-cells (not shown). For this type of analysis the significance 
threshold was set at p≤0.0016 (Bonferroni multiple endpoint correction, 31 end-points).  
 
In order to reduce the complexity of the information we determined the proportions of T-
cell subsets with specific numbers of parallel functions (1 to 5) (Fig. 1A). These were 
very similar in young and older people, except for a slightly (but significantly) higher 
proportion of UL83-specific CD4 T-cells with two functions observed in the older people. 
We also studied the total percentage of cells expressing each activation marker in order 
to explore functional marker dominance (note that such subsets overlap). However, no 
significant differences were visible (Fig. 1B). Nevertheless, the data shown in Fig. 1 and 
supplementary Fig. 2 suggests that many smaller subset differences might exist and the 
lack of statistical significance could be due to the small group sizes particularly among 
the young. The number of articipants with a UL55-specific CD4 and UL123-specific 
CD8 T-cell responses were only 6/26 and 9/26 among the young, but these were the 
second and third most frequently recognized proteins in the study. This meant it was 
highly unlikely that we would be able to recruit sufficient numbers of responders for 
each protein in order to complete a representative comparison between the age groups 
protein by protein. We therefore decided to base the comparison of polyfunctionality on 
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all present T-cell responses in the two age groups, irrespective of the recognized target 
protein. In addition, we decided to use an algorithm that would assign an aggregate 
measure of polyfunctionality to each response, because interpreting group differences 
with respect to multiple percentages of subsets with slightly different functional 
characteristics appeared to be too complex. We, therefore, applied the recently 
introduced polyfunctionality index (PI) to our data. The PI is a compound measure, 
which elegantly reduces the complexity inherent in multiple subset comparisons to a 
single index number [15, 16].  
 
The PI is very similar in the young and older UK groups but lower in the oldest 
old ‘survivors’ 
We first determined the PI for every single response and then the average PI for CD4 
and CD8 T-cell responses in each individual. This allowed us to include all responses to 
all 19 proteins in our comparison. Surprisingly, the average PI appeared to be slightly 
higher in the older participants, but this difference was not statistically significant (Fig. 
2A).  
However, the oldest old, who were considered examples of exceptionally successful 
ageing, showed a significantly lower PI in their CD4 and CD8 T-cell responses than the 
older participants (Fig. 2B). When comparing the UL83-specific T-cell response 
between the older and the oldest old in more detail using SPICE [14], larger 
percentages of functionally focused subsets (one or two functions) present in the latter 
were consistent with this observation (Supplementary Fig. S3). In particular, they had 
higher frequencies of UL83-specific CD4 T-cells up-regulating CD154 and IFN- or 
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degranulation alone. Among UL83-specific CD8 T-cells the subsets displaying IFN- 
alone or IFN-and degranulation were significantly increased compared to the older 
group. The subset displaying degranulation alone also seemed markedly increased but 
this difference did not achieve statistical significance. Concerning UL55-specific CD4 T-
cell responses, the oldest old had higher frequencies of the subset displaying only 
degranulation (mirroring the UL-83 specific response) but there were no differences in 
the other subsets (data not shown). For UL123-specific CD8 T-cells, by contrast, no 
significant differences were found (data not shown).  
 
Polyfunctionality varies between responses targeting different proteins but is 
related to response size 
We also applied the PI to the comparison of protein-specific responses among the UK 
cohort (young and older together). For this purpose we selected the 5 most frequently 
recognized CD4 and CD8 T-cell target proteins. Whilst differences for CD4 T-cells were 
apparent but not statistically significant (Fig 2C, left), significant differences were 
observed for CD8 T-cells (Fig. 2C, right). In order to elicit how individual functional 
subsets reflected these differences for the most frequently recognized proteins we used 
SPICE [14]. Visualization of all individual subsets suggested that UL55-specific CD4 T-
cells included significantly larger subsets displaying IFN- and TNF, or IFN-, TNF and 
degranulation (CD107) than UL83-specific CD4 T-cells. Meanwhile, UL123-specific CD8 
T-cells included significantly larger subsets displaying IFN- and TNF in combination or 
alone than UL83-specific CD8 T-cells (Supplementary Fig. S4). An increase of subsets 
focused on single effector markers is consistent with a loss of polyfunctionality. 
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Interestingly, there seemed to be different ‘levels’ of polyfunctionality for responses 
targeting different proteins (Fig. 3 B). Of note, these levels per se did not seem to 
depend on whether average responses to a protein were large or small. For example, 
UL123 induced significantly larger CD8 T-cell responses than UL83 (Fig. 2C, bottom 
right), but the responses to UL83 were significantly more polyfunctional (Fig. 2C, top 
right). A similar trend was seen for CD4 T-cell responses to UL55 (bigger) and UL83 
(more polyfunctional) but differences were not significant. However, with respect to 
individual proteins, there was a significant association between PI and response size. 
This was observed for CD4 T-cell responses to UL83 and UL55 (Fig. 2D, top) as well 
as for CD8 T-cell responses to UL83 and UL123 (Fig. 2D, bottom). Similar but 
statistically non-significant associations between response size and PI were observed 
for one additional CD8 and two additional CD4 protein targets among the top 5 
recognized proteins in each T-cell compartment (the numbers of cases were lower than 
for the three dominant proteins mentioned above). 
Finally, the differences in PI between UL83 and UL55-specific CD4 T-cells as well as 
UL83 and UL123-specific CD8 T-cells (p=0.018 and p=0.066, respectively, data not 
shown) were preserved in the oldest old, albeit not statistically significant in CD8 T-cells. 
An association between response size and PI was visible in the oldest old for the same 
proteins as in the UK cohort but only as a non-significant trend (due to a lack of 
sufficient numbers of observations, data not shown).  
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Discussion 
The present study provides a comprehensive analysis of the polyfunctionality of CMV-
specific T-cells at different ages.  It covers CD4 and CD8 T-cell responses to 19 
different CMV target proteins, examines healthy participants in two different age groups, 
and also includes a cohort of successfully aged, oldest old, for comparison. We 
analyzed five simultaneous functional readouts and applied the recently introduced PI in 
addition to conventional subset-by-subset analysis. Use of the PI enabled us to analyze 
(aggregate) polyfunctionality in individuals and groups of individuals, responses to 
different proteins, as well as correlations between polyfunctionality and response size.  
Our results agree with published reports indicating that age per se is not linked to 
reduced polyfunctionality of CD8 T-cell responses to a range of different organisms [17] 
or altered CD4 and CD8 T-cell responses to superantigens [18]. For statistical 
robustness, when comparing the PI between T-cell responses of different protein 
specificities we focused on the most frequently recognized ones (U83, UL123, UL55).  
But when comparing the PI of CMV-specific T-cell responses between age groups, all 
responses to all proteins were accounted for. Since for each individual, the average PI 
across their specific CD4 and CD8 T-cell responses was computed prior to comparing 
these averages betwe n the age groups, our approach provided unprecedented 
coverage of CMV target proteins for the analysis of polyfunctionality. It convincingly 
demonstrates that ageing within the expected lifespan in the UK (and many other 
countries in the world) has no obvious detrimental effect on the functional diversity of 
CMV-specific T-cells.  
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With respect to what determines T-cell polyfunctionality, it is interesting that responses 
to different target proteins had different PIs. This might be explained by the presentation 
of different CMV proteins by APCs in different contexts [19] and/or the efficiency of 
antigen presentation, including T-cell receptor antigen sensitivity and the amount of 
antigen available [20]. It is conceivable that the same protein might elicit responses of 
different polyfunctionality (and magnitude) in cohorts of different genetic background, 
i.e. certain HLA-types might contribute to the presentation of peptides that are 
recognized with higher TCR affinity and avidity than others [21]. These aspects clearly 
warrant further study.   
In addition, a striking and significant association between the PI and CD4 and/or CD8 T-
cell response size was observed for responses to UL83, UL123, and UL55 in the young 
and older donors. It remains unclear whether this holds generally true for sub-dominant 
proteins. In the oldest old we saw the same trend that polyfunctionality increased with 
response size but there were not enough cases for correlations to reach statistical 
significance.  
The present study significantly extends recent work in a large group of (exclusively) 
older people with respect to UL83-specific T-cell responses. That study showed a 
correlation between the increase of certain polyfunctional subsets (for example 
exhibiting TNF, IFN-, Perforin expression as well as degranulation) and the size of the 
UL83-specific T-cell response. However, unlike in the present study, T-cell 
polyfunctionality was not assessed by an aggregate measure such as the PI and other 
proteins were not included. Also, a comparison between older and oldest old was not 
made.  
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Perhaps unexpectedly, results in the oldest old demonstrated decreased 
polyfunctionality, with an overall reduced PI of both CD4 and CD8 T-cell responses. In 
agreement with this, our detailed subset analysis indicated that several subsets with just 
one or two of the measured functions were increased (e.g. CD8 T-cells displaying IFN- 
alone, or IFN- and degranulation). Studies conducted over a decade ago suggested 
that in very old people the expansion of UL83-specific T-cells (recognizing specific 
epitopes in a narrow HLA-context) was linked to functional exhaustion [22, 23]. The 
individuals examined in that work were similar in age to our oldest old group and the 
decrease in polyfunctionality we have measured in this group might be a correlate of the 
‘functional exhaustion’ reported in these earlier studies, which used fewer activation 
markers.  
In any case, it seems to go against the notion that higher polyfunctionality is associated 
with better protection if it is reduced in the oldest old [15]. Protection from CMV-disease 
(probably the most important role of CMV-specific T-cells) might well be provided by a 
very small number of CMV-specific cells [10], but decreased polyfunctionality of large 
responses in very old people might reduce CMV-associated immune pathology. Such 
may include for example vascular pathology contributing to cardiovascular events and 
stroke, which are major causes of death in older people [12, 24-27]. It is important to 
remember in this context, that cells with greater polyfunctionality also produce larger 
and potentially more harmful quantities of effector cytokines [9]. A link between CMV-
specific T-cell polyfunctionality and increased immune pathology would undermine the 
idea that T-cell polyfunctionality at older ages is necessarily a good thing. It might be of 
advantage for long-term survival, by contrast, if the level of pathogen control is balanced 
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against the risk of ‘collateral’ tissue damage. Maybe this is achieved to an extent by 
reduced polyfunctionality of CMV-specific T-cell responses in very old people. This is an 
important question to be answered in light of the growing interest in the possible role of 
CMV in a range of age-associated pathologies [28-30].  
In conclusion, our study has revealed new aspects of CMV-specific T-cell 
polyfunctionality, in particular the previously unknown effects of target protein specificity 
and response size. While we now have a better understanding of this complex issue, 
the discovery that T-cell polyfunctionality in the oldest old long term ‘survivors’ is 
actually reduced has raised the question if increased T-cell polyfunctionality  in older 
people could potentially limit survival. 
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Figure Legends 
Fig. 1: The functional T-cell response composition in young and older people 
appears very similar. PBMC from CMV+ donors were stimulated overnight with 19 
CMV protein-derived overlapping peptide-pools. Activated T cells and their functional 
composition were analyzed by flow-cytometry, including the activation markers, 
degranulation (CD107), CD154, IL-2, TNF, and IFN-. Responses from the UK cohort 
are shown for the two most frequently targeted proteins for each T-cell subset. (A) Non-
overlapping subsets exhibiting 5, 4, 3, or 2 parallel functions or just 1 single function are 
shown as a proportion of the specifically activated T-cells (order of decreasing 
polyfunctionality). A significant difference between the age groups is observed for UL-83 
specific CD4 T-cells with 2 functions but on the whole subset distributions appear very 
similar (significance threshold set at p≤0.01, Mann-Whitney test, Bonferroni multiple 
endpoint correction, 5 end-points). (B) The functional dominance of each activation 
marker in a given response is assessed by the proportion of activated cells expressing 
it. Some variability between proteins is revealed but no significant differences between 
the age groups (significance threshold set at p≤0.01, Mann-Whitney test, Bonferroni 
multiple endpoint correction, 5 end-points).  
 
Fig. 2: The polyfunctionality index of CMV-specific T-cell responses varies 
between protein targets and is reduced in the oldest old. The polyfunctionality index 
(PI) captures functional subset distributions by weighting the number of functions as 
well as subset size [15, 16]. For the present study a linear relationship between the 
number of functions and the relative weight of a subset was selected (e.g. subsets with 
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two functions were assigned twice the weight of subsets with one function, subsets with 
three functions were assigned three times the weight of subsets with one function, etc.). 
(A) In each individual the PI was calculated for all positive responses and averaged. Dot 
plots show the distribution of the average PI in young and older UK individuals for CD4 
and CD8 T-cells. No significant differences between the groups were observed. (B) The 
comparison of the average PI between the older and the oldest old reveals significantly 
reduced polyfunctionality in the latter. (C) The PI of CD4 and CD8 T-cell responses is 
shown by target protein for the 5 most frequently recognized proteins in each T-cell 
compartment (each protein was recognized by 10 or more donors, only young and older 
UK donors were included in this analysis). Differences apparent for CD4 T-cells were 
not statistically significant (Kruskal-Wallis Test), but the data suggests that responses to 
UL83 were the most polyfunctional (upper left). However, significant differences are 
revealed for CD8 T-cells (upper right). Responses to UL83 showed the highest and 
responses to UL32 the lowest polyfunctionality.  Lower panels show T-cell response 
size for each target protein (CD4 T-cells on the left, CD8 T-cells on the right), box plots 
show median, interquartile range, and outliers (o). (D) Interestingly, with respect to each 
analyzed protein, the PI significantly correlated with response size in a linear fashion. 
Correlations were moderate to strong. The strongest correlation was found for CD4 T-
cell responses to UL83 (only UK donors were included in this analysis).  
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Tables 
 
Table 1. CMV+ participant demographics (UK and Italy) 
Parameter UK ‘young’ UK ‘older’ ‘oldest old’ 
Total number 26 69 22 
Age range (mean ± STD) 19 – 35 
(23.3±4.2) 
60 – 85 
(69.0±7.5) 
85 - 103 
(95.9±5.9) 
Females 18 (69 %) 35 (51 %) 16 (73%) 
Males 8 (31 %) 34 (49 %) 6 (27%) 
White (British or Italian) 18 (69%) 69 (100 %) 22 (100%) 
Non-White Britisha 8 (31%) 0 (0%) 0 (0%) 
aNon-white British young adults included 1 Syrian, 2 Indian, 1 Sri-Lankan, 1 
Bangladeshi, 1 Malaysian, 1 White/Asian and 1 Black African/Asian participants. 
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Table 2: CMV peptide-pools used for stimulation 
Tube Protein(s) No. of Peptides 
1 UL555 224 
2 UL83 138 
3 UL86 340 
4 UL122 120 
5 UL123 143 
6 UL99 45 
7 UL153 67 
8 UL32 260 
9 UL28 92 
10 UL48Aa 281 
11 UL48Ba 281 
12 US3 44 
13 UL151& UL82 219 (82+137) 
14 UL94 & US29 197 (84+113) 
15 UL103 & US32 103 (60+43) 
16 US24 & UL36 240 (123+117) 
a UL48 was divided into two pools for stimulation (UL48A and UL48B),however, results were 
combined 
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